Short answer · Medically reviewed summary · Last updated: 2026-04-07
TL;DR: Brugada Syndrome is a rare, inherited heart rhythm disorder that disrupts the electrical activity of the heart, significantly increasing the risk of dangerous, irregular heartbeats known as arrhythmias. While many individuals with Brugada Syndrome remain asymptomatic, the condition can lead to sudden cardiac arrest if not properly managed through medical monitoring and interventions like an Implantable Cardioverter Defibrillator (ICD). What exactly is Brugada Syndrome? Brugada Syndrome is a genetic channelopathy, meaning it is caused by a dysfunction in the "channels" that regulate the flow of ions (such as sodium, potassium, and calcium) in and out of the heart's muscle cells.
TL;DR: Brugada Syndrome is a rare, inherited heart rhythm disorder that disrupts the electrical activity of the heart, significantly increasing the risk of dangerous, irregular heartbeats known as arrhythmias. While many individuals with Brugada Syndrome remain asymptomatic, the condition can lead to sudden cardiac arrest if not properly managed through medical monitoring and interventions like an Implantable Cardioverter Defibrillator (ICD).
Brugada Syndrome is a genetic channelopathy, meaning it is caused by a dysfunction in the "channels" that regulate the flow of ions (such as sodium, potassium, and calcium) in and out of the heart's muscle cells. This electrical instability can cause the heart to beat dangerously fast or in a chaotic, ineffective rhythm. Because the heart structure itself often appears normal on standard imaging like echocardiograms, Brugada Syndrome is frequently referred to as a "hidden" or "electrical" heart disease.
The primary system affected is the cardiovascular system, specifically the heart's electrical conduction system. In patients with Brugada Syndrome, the altered ion flow—most commonly due to a mutation in the SCN5A gene—shortens the electrical recovery period of the heart muscle. This creates a vulnerability where the heart can enter ventricular fibrillation, a state where the lower chambers of the heart quiver instead of pumping blood effectively. If left untreated, this can lead to syncope (fainting) or sudden cardiac death.
Brugada Syndrome is considered a rare disease, though its exact prevalence is difficult to determine because many people are unaware they have it. Current estimates suggest it affects approximately 1 in 2,000 to 1 in 5,000 people globally. Key demographic factors include:
Unlike many other heart conditions, Brugada Syndrome is not typically associated with structural heart disease, such as thickened heart walls or damaged valves. Key differentiating features include:
Currently, 228 people with Brugada Syndrome have joined the DiseaseMaps community, sharing their personal experiences with diagnosis and management strategies to help others navigate this rare condition.
Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.